AudioEye chairman reports Sero Capital share sales

The shares were held through Sero Capital LLC; David Moradi separately reported direct holdings of 797,595 shares.

Available on EDGAR 11/06/2026 - 06:01 PM EST Accepted by SEC EDGAR 11/06/2026 - 06:00 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

AudioEye, Inc. Executive Chairman and CPO David Moradi reported sales of common stock held by Sero Capital LLC: 20,895 shares at a weighted average price of $12.6724 per share and 1,464 shares at a weighted average price of $13.3796 on November 4, 2026. The reported sale-price ranges were $12.315 to $13.31 and $13.32 to $13.58, respectively. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Seller: 22,359 shares

Net Sell 2 txns

Insider Moradi David

Role EXECUTIVE CHAIRMAN AND CPO

Sold 22,359 shs ($284K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	20,895	$12.6724	$265K
Sale	Common Stock F3, F2	1,464	$13.3796	$20K
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,749,607 shares (Indirect, Through Sero Capital LLC); Common Stock — 797,595 shares (Direct)

Footnotes (3)

1. F1. Reflects the weighted average price of 20,895 shares of common stock of AudioEye, Inc. sold by the reporting person in multiple transactions on November 4, 2026 with sale prices ranging from $12.315 to $13.31 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
2. F2. Securities of the Issuer held directly by Sero Capital LLC ("Sero Capital"). David Moradi is the Managing Partner of Sero Capital and may be deemed to direct all voting and investment decisions made by Sero Capital.
3. F3. Reflects the weighted average price of 1,464 shares of common stock of AudioEye, Inc. sold by the reporting person in multiple transactions on November 4, 2026 with sale prices ranging from $13.32 to $13.58 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold through Sero Capital LLC: 20,895 shares Weighted average sale price: $12.6724 per share Shares sold through Sero Capital LLC: 1,464 shares +2 more

5 metrics

Shares sold through Sero Capital LLC 20,895 shares November 4, 2026; weighted average price $12.6724 per share

Weighted average sale price $12.6724 per share For 20,895 shares sold November 4, 2026

Shares sold through Sero Capital LLC 1,464 shares November 4, 2026; weighted average price $13.3796 per share

Weighted average sale price $13.3796 per share For 1,464 shares sold November 4, 2026

David Moradi direct holdings 797,595 shares As of November 4, 2026

Key Terms

weighted average price, Rule 10b5-1 plan, voting and investment decisions

3 terms

weighted average price financial

"weighted average price of 20,895 shares"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Rule 10b5-1 plan regulatory

"No Rule 10b5-1 plan is reported"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

voting and investment decisions technical

"direct all voting and investment decisions made by Sero Capital"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AEYE shares were sold through Sero Capital LLC?

Sero Capital LLC reported sales of 20,895 shares at a weighted average price of $12.6724 per share and 1,464 shares at a weighted average price of $13.3796 on November 4, 2026. The sale-price ranges were $12.315 to $13.31 and $13.32 to $13.58, respectively. No Rule 10b5-1 plan is reported.

How many shares of AEYE did David Moradi hold directly?

David Moradi reported direct holdings of 797,595 shares of AudioEye common stock as of November 4, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moradi David

(Last) (First) (Middle)

119 WASHINGTON AVE.

SUITE 402

(Street)

MIAMI BEACH FLORIDA 33139

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AUDIOEYE INC [ AEYE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	EXECUTIVE CHAIRMAN AND CPO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/04/2026		S		20,895	D	$12.6724(1)	1,751,071	I	Through Sero Capital LLC(2)
Common Stock	11/04/2026		S		1,464	D	$13.3796(3)	1,749,607	I	Through Sero Capital LLC(2)
Common Stock								797,595	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the weighted average price of 20,895 shares of common stock of AudioEye, Inc. sold by the reporting person in multiple transactions on November 4, 2026 with sale prices ranging from $12.315 to $13.31 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

2. Securities of the Issuer held directly by Sero Capital LLC ("Sero Capital"). David Moradi is the Managing Partner of Sero Capital and may be deemed to direct all voting and investment decisions made by Sero Capital.

3. Reflects the weighted average price of 1,464 shares of common stock of AudioEye, Inc. sold by the reporting person in multiple transactions on November 4, 2026 with sale prices ranging from $13.32 to $13.58 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

	/s/ Christine G. Long, Attorney-in-Fact	11/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)